...
首页> 外文期刊>Clinical & developmental immunology. >Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers
【24h】

Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers

机译:TLRS和细胞因子的病毒调节以及HPV相关癌症的相关免疫疗法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The modulation of the host innate immune system is a well-established carcinogenesis feature of several tumors, including human papillomavirus- (HPV-) related cancers. This virus is able to interrupt the initial events of the immune response, including the expression of Toll-like receptors (TLRs), cytokines, and inflammation. Both TLRs and cytokines play a central role in HPV recognition, cell maturation and differentiation as well as immune signalling. Therefore, the imbalance of this sensitive control of the immune response is a key factor for developing immunotherapies, which strengthen the host immune system to accomplish an efficient defence against HPV and HPV-infected cells. Based on this, the review is aimed at exposing the HPV immune evasion mechanisms involving TLRs and cytokines and at discussing existing and potential immunotherapeutic TLR- and cytokine-related tools.
机译:主体先天免疫系统的调节是几种肿瘤的良好致癌特征,包括人乳头瘤病毒 - (HPV-)相关癌症。该病毒能够中断免疫应答的初始事件,包括表达Toll样受体(TLR),细胞因子和炎症。 TLR和细胞因子均在HPV识别,细胞成熟和分化中发挥着中心作用以及免疫信号传导。因此,对免疫反应的这种敏感控制的不平衡是显影免疫疗法的关键因素,其强化宿主免疫系统,以实现对抗HPV和HPV感染细胞的有效防御。基于这一点,审查旨在暴露涉及TLR和细胞因子的HPV免疫逃避机制,并讨论现有和潜在免疫治疗性TLR和细胞因子相关工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号